The utility of 11C-choline PET/CT in prostate patients of PSA failure - 11C-choline PET/CT in PSA failure

Radiology, Hyogo College of Medicine0 sites20 target enrollmentOctober 1, 2015

ConditionsProstate Cancer

Overview

Phase: 未知
Intervention: Not specified
Conditions: Prostate Cancer
Sponsor: Radiology, Hyogo College of Medicine
Enrollment: 20
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

Twenty Japanese prostate cancer patients underwent 11C-choline and FDG PET/CT. The sensitivity/specificity/accuracy/AUC for choline-PET for diagnosing local lesions were 90.9%/100%/95.0%/1.0, whereas those for FDG-PET were 45.5%/100%/75.0%/0.773. Those for choline-PET for node metastasis were 88.9%/100%/95.0%/0.944, and those for FDG-PET were 44.4%/100%/75.0%/0.722. Those for choline-PET for bone metastasis were 84.6%/100%/90.0%/0.951, and those for FDG-PET were 76.9%/100%/85.0%/0.962.

Registry

who.int

Start Date

October 1, 2015

End Date

December 31, 2025

Last Updated

2 years ago

Study Type

Interventional

Sex

Male

Investigators

Sponsor

Radiology, Hyogo College of Medicine

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•\*The patients who cannot keep face up position because of sharp pain in succession for around 30 minutes. \*The patients with the extreme claustrophobia. \*The patients whom the ADL which I become independent and can inspect is not kept. \*The patients who a study person in charge is judged to be inappropriate.